Kuncic works across medical physics and nanoscale systems: nanoparticle-enhanced radiotherapy and dosimetry (where high-Z nanoparticles act as local dose amplifiers and the physics question is energy deposition at nanometre scales), nanoparticle contrast agents and theranostics, and — separately — neuromorphic nanowire networks as physical computing substrates. The medical-physics thread is the relevant one here: it is about quantifying and imaging what a nanoscale probe does inside tissue. Positioned against the established body of NV-ensemble quantum sensing work — DEER, nanoscale NMR and T1 relaxometry protocols operating at pT/sqrt(Hz) field sensitivity — the nanoparticle-in-tissue problem she works on is the same delivery-and-quantification problem that determines whether an in-cell nanodiamond sensor operating near the pT/sqrt(Hz) regime reports anything biologically meaningful. Borderline inclusion; a candidate would be bringing quantum sensing to her, not the reverse.

Pankhurst directs the UCL Healthcare Biomagnetics Laboratory, developing magnetic nanoparticles and instrumentation for clinical use: AC-susceptometry-based sentinel-lymph-node localization for breast cancer surgical staging (commercialized as Endomag), magnetic particle imaging, and magnetic hyperthermia therapy. He is a participant in the Q-BIOMED quantum-biomedical-sensing hub, connecting magnetic biosensing with the hub's broader quantum-diagnostics translation effort.

Tilley directs the UNSW Electron Microscope Unit and runs a nanomaterials group whose distinctive capability is in-situ liquid-cell TEM: watching nanoparticle nucleation, growth and catalytic transformation in real time inside the microscope, in liquid, rather than inferring mechanism from before-and-after snapshots. The synthetic side produces magnetic and plasmonic nanoparticles used as biosensor labels and MRI contrast agents, largely in collaboration with Gooding and Reece. Positioned against the established body of NV-ensemble quantum sensing work — DEER, nanoscale NMR and T1 relaxometry protocols operating at pT/sqrt(Hz) field sensitivity — the group is a supplier and characteriser of the nanoparticle probes that in-cell quantum sensing depends on — including the magnetic-nanoparticle labels whose stray fields a pT/sqrt(Hz) NV sensor would actually detect — and the liquid-cell TEM capability is a rare way to validate what those particles are doing in situ. Borderline inclusion (materials characterisation rather than sensing), kept for the collaborative infrastructure it represents.